Entecavir Tablet, Film Coated
Product Images NDC 68382-921

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Entecavir (NDC 68382-921). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Entecavir (6a6210fe C8ca 4db3 B0c2 571b64489ea9 01)

Chemical structure diagram of Entecavir, showing the molecular arrangement including hydroxyl groups, nitrogen atoms, and a water molecule (H2O) associated with the compound.*

FDA Label Image

Entecavir Tablets (6a6210fe C8ca 4db3 B0c2 571b64489ea9 02)

Label for Entecavir Tablets, USP 0.5 mg oral film-coated tablets. The package contains 30 tablets. It is labeled for prescription use only and manufactured by Cadila Healthcare Ltd., distributed by Zydus Pharmaceuticals USA Inc. Storage and dispensing instructions are included on the label.*

FDA Label Image

Entecavir Tablets (6a6210fe C8ca 4db3 B0c2 571b64489ea9 03)

Entecavir Tablets, USP 1 mg film-coated tablets in a 30-count package from Zydus Pharmaceuticals USA Inc. The label includes instructions for pharmacists to dispense patient information and storage details recommending controlled room temperature and protection from light. The tablets are round and brown with the imprint '921'.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.